Divis Laboratories will spend Rs 15 billion for expanding its existing facilities over the next 15 months. It is a maker of active pharmaceutical ingredients (APIs) and drug intermediates.
The company would invest Rs 6 billion each on its Unit-2 at the Vizag SEZ, Andhra, and Unit-1 of its Nalgonda SEZ, Telangana. It will also invest another Rs 3 billion for de-bottlenecking at Vizag.
All the work is likely to be finished by the end of December. Currently, Divis Laboratories is operating four multipurpose manufacturing facilities.
The company is making the investment to cater to the rising opportunities in generic and big pharmaceutical businesses.
